| COVID-19 and Mental Health | Lifetime | 11 | GB 3 | 99.72 |
| Long-Term Effects of COVID-19 | Lifetime | 19 | GB 4 | 99.56 |
| COVID-19 Clinical Research Studies | Lifetime | 89 | GB 8 | 99.41 |
| Nutrition and Health in Aging | Lifetime | 127 | GB 9 | 99.33 |
| Physical Activity and Health | Lifetime | 64 | GB 6 | 99.40 |
| Obesity, Physical Activity, Diet | Lifetime | 253 | GB 34 | 99.30 |
| Health disparities and outcomes | Lifetime | 190 | GB 37 | 99.04 |
| Frailty in Older Adults | Lifetime | 158 | GB 12 | 98.50 |
| Health and Lifestyle Studies | Lifetime | 199 | GB 15 | 98.34 |
| Chronic Disease Management Strategies | Lifetime | 245 | GB 47 | 98.18 |
| Eating Disorders and Behaviors | Lifetime | 274 | GB 39 | 98.12 |
| Food Security and Health in Diverse Populations | Lifetime | 239 | GB 14 | 97.84 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 783 | GB 55 | 97.56 |
| COVID-19 and healthcare impacts | Lifetime | 491 | GB 83 | 94.54 |
| Body Composition Measurement Techniques | Lifetime | 325 | GB 33 | 96.86 |
| Urban Transport and Accessibility | Lifetime | 575 | GB 55 | 96.87 |
| Sexual function and dysfunction studies | Lifetime | 521 | GB 29 | 95.30 |
| Suicide and Self-Harm Studies | Lifetime | 647 | GB 64 | 95.45 |
| Children's Physical and Motor Development | Lifetime | 690 | GB 59 | 94.71 |
| Balance, Gait, and Falls Prevention | Lifetime | 888 | GB 54 | 94.37 |
| COVID-19 Impact on Reproduction | Lifetime | 758 | GB 56 | 88.07 |
| Restless Legs Syndrome Research | Lifetime | 994 | GB 45 | 79.23 |
| Discrimination and Equality Law | Lifetime | 687 | GB 150 | 48.67 |
| Food Security and Health in Diverse Populations | 2021-2025 | 1 | GB 1 | 99.67 |
| COVID-19 and Mental Health | 2021-2025 | 8 | GB 4 | 99.82 |
| Chronic Disease Management Strategies | 2021-2025 | 2 | GB 2 | 99.71 |
| Health disparities and outcomes | 2021-2025 | 3 | GB 3 | 99.78 |
| Nutrition and Health in Aging | 2021-2025 | 3 | GB 1 | 99.84 |
| Frailty in Older Adults | 2021-2025 | 7 | GB 1 | 99.60 |
| Long-Term Effects of COVID-19 | 2021-2025 | 19 | GB 6 | 99.58 |
| Obesity, Physical Activity, Diet | 2021-2025 | 18 | GB 1 | 99.52 |
| Physical Activity and Health | 2021-2025 | 12 | GB 3 | 99.46 |
| Child Nutrition and Feeding Issues | 2021-2025 | 21 | GB 6 | 98.21 |
| COVID-19 Clinical Research Studies | 2021-2025 | 203 | GB 24 | 98.94 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 91 | GB 17 | 98.59 |
| COVID-19 and healthcare impacts | 2021-2025 | 189 | GB 45 | 96.17 |
| Suicide and Self-Harm Studies | 2021-2025 | 59 | GB 10 | 97.90 |
| Body Composition Measurement Techniques | 2021-2025 | 34 | GB 3 | 97.50 |
| Nutritional Studies and Diet | 2021-2025 | 137 | GB 13 | 97.80 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 724 | GB 66 | 97.15 |
| Homelessness and Social Issues | 2021-2025 | 137 | GB 14 | 94.79 |
| Balance, Gait, and Falls Prevention | 2021-2025 | 124 | GB 10 | 94.61 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 380 | GB 27 | 96.72 |
| Ophthalmology and Visual Impairment Studies | 2021-2025 | 148 | GB 11 | 95.33 |
| Mental Health Treatment and Access | 2021-2025 | 238 | GB 47 | 94.68 |
| Child Nutrition and Water Access | 2021-2025 | 386 | GB 28 | 94.00 |
| Eating Disorders and Behaviors | 2021-2025 | 281 | GB 37 | 93.88 |
| Sleep and related disorders | 2021-2025 | 376 | GB 17 | 93.58 |
| Cerebral Palsy and Movement Disorders | 2021-2025 | 392 | GB 14 | 92.02 |
| Health and Lifestyle Studies | 2021-2025 | 212 | GB 4 | 90.94 |
| COVID-19 Impact on Reproduction | 2021-2025 | 466 | GB 37 | 88.12 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 846 | GB 79 | 88.77 |
| Maternal Mental Health During Pregnancy and Postpartum | 2021-2025 | 735 | GB 77 | 88.25 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 911 | GB 63 | 88.49 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 469 | GB 62 | 84.05 |
| Restless Legs Syndrome Research | 2021-2025 | 89 | GB 4 | 87.86 |
| Diabetes Management and Education | 2021-2025 | 405 | GB 45 | 84.62 |
| Psychological Well-being and Life Satisfaction | 2021-2025 | 429 | GB 31 | 85.42 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 541 | GB 42 | 84.59 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 534 | GB 69 | 83.56 |
| Iron Metabolism and Disorders | 2021-2025 | 685 | GB 53 | 83.26 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 236 | GB 23 | 80.13 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 810 | GB 41 | 79.60 |
| Dermatological and COVID-19 studies | 2021-2025 | 201 | GB 6 | 74.96 |
| Pregnancy and Medication Impact | 2021-2025 | 743 | GB 62 | 76.10 |
| Aging, Health, and Disability | 2021-2025 | 250 | GB 5 | 75.97 |
| Electrolyte and hormonal disorders | 2021-2025 | 443 | GB 25 | 73.33 |
| Health and Wellbeing Research | 2021-2025 | 659 | GB 7 | 72.68 |
| Health, psychology, and well-being | 2021-2025 | 671 | GB 104 | 69.32 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 389 | GB 18 | 69.30 |
| Family Caregiving in Mental Illness | 2021-2025 | 450 | GB 73 | 67.48 |
| Obesity and Health Practices | 2021-2025 | 998 | GB 133 | 67.97 |
| Older Adults Driving Studies | 2021-2025 | 227 | GB 7 | 66.63 |
| Drug-Induced Adverse Reactions | 2021-2025 | 926 | GB 33 | 66.31 |
| Poxvirus research and outbreaks | 2021-2025 | 980 | GB 66 | 63.56 |
| Magnesium in Health and Disease | 2021-2025 | 306 | GB 9 | 60.00 |
| Sports, Gender, and Society | 2021-2025 | 940 | GB 165 | 57.04 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 691 | GB 96 | 53.13 |
| Discrimination and Equality Law | 2021-2025 | 49 | GB 3 | 52.77 |